Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.25.1 (
proteasome
)
28,817
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The voltage-gated potassium channel Kv3.3 is the causative gene of
SCA13
(spinocerebellar ataxia type 13), an autosomal dominant neurological disorder. The four dominant mutations identified to date cause Kv3.3 channels to be non-functional or have altered gating properties in Xenopus oocytes. In the present paper, we report that
SCA13
mutations affect functional as well as protein expression of Kv3.3 channels in a mammalian cell line. The reduced protein level of
SCA13
mutants is caused by a shorter protein half-life, and blocking the ubiquitin-
proteasome
pathway increases the total protein of
SCA13
mutants more than wild-type.
SCA13
mutated amino acids are highly conserved, and the side chains of these residues play a critical role in the stable expression of Kv3.3 proteins. In addition, we show that mutant Kv3.3 protein levels could be partially rescued by treatment with the chemical chaperone TMAO (trimethylamine N-oxide) and to a lesser extent with co-expression of Kv3.1b. Thus our results suggest that amino acid side chains of
SCA13
positions affect the protein half-life and/or function of Kv3.3, and the adverse effect on protein expression cannot be fully rescued.
...
PMID:Spinocerebellar ataxia-13 Kv3.3 potassium channels: arginine-to-histidine mutations affect both functional and protein expression on the cell surface. 2373 63